No Red Tape For Addiction Treatment Act

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. 3522 Introduced in Senate (IS)]

<DOC>






119th CONGRESS
  1st Session
                                S. 3522

  To amend title XIX of the Social Security Act to require that State 
  Medicaid programs provide at least one formulation of each type of 
   medication for the treatment of opioid use disorder without prior 
    authorization or limitations on dosage, and for other purposes.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                           December 17, 2025

Ms. Hassan (for herself and Mr. Justice) introduced the following bill; 
     which was read twice and referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL


 
  To amend title XIX of the Social Security Act to require that State 
  Medicaid programs provide at least one formulation of each type of 
   medication for the treatment of opioid use disorder without prior 
    authorization or limitations on dosage, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``No Red Tape For Addiction Treatment 
Act''.

SEC. 2. PROVISION OF MEDICATION-ASSISTED TREATMENT FOR OPIOID USE 
              DISORDER WITHOUT PRIOR AUTHORIZATION OR LIMITATIONS ON 
              DOSAGE UNDER MEDICAID.

    (a) In General.--Section 1905 of the Social Security Act (42 U.S.C. 
1396d) is amended--
            (1) in subsection (a)(29), by striking ``(2) and (3)'' and 
        inserting ``(2), (3), and (4)''; and
            (2) in subsection (ee), by adding at the end the following 
        new paragraph:
            ``(4) Provision of medication-assisted treatment without 
        prior authorization.--
                    ``(A) In general.--A State plan (or a waiver of 
                such plan) shall provide coverage of at least 1 
                formulation of each drug and biological product 
                described in paragraph (1)(A) (which shall include, if 
                available with respect to such a drug or biological 
                product, a formulation that is long-lasting and 
                injectable) that is not subject to prior authorization 
                or limitations on dosage as a condition of coverage or 
                payment for such drug or biological product.
                    ``(B) Rule of construction.--The requirement under 
                subparagraph (A) to provide coverage of at least 1 
                formulation of each drug and biological product 
                described in paragraph (1)(A) shall not be construed as 
                modifying or limiting the ability of a State to 
                establish a formulary that is consistent with the 
                requirements of section 1927(d)(4).''.
    (b) Conforming Amendment.--Section 1927(d)(1)(A) of the Social 
Security Act (42 U.S.C. 1396r-8(d)(1)(A)) is amended by striking ``A 
State'' and inserting ``Except as provided in section 1905(ee)(4), a 
State''.
    (c) Effective Date.--
            (1) In general.--Subject to paragraph (2), the amendments 
        made by this subsection shall apply with respect to medical 
        assistance provided on or after the date that is 1 year after 
        the date of enactment of this Act.
            (2) Exception for state legislation.--In the case of a 
        State plan under title XIX of the Social Security Act (42 
        U.S.C. 1396 et seq.) that the Secretary of Health and Human 
        Services determines requires State legislation in order for 
        such plan to meet any requirement imposed by the amendments 
        made by this section, such plan shall not be regarded as 
        failing to comply with the requirements of such title solely on 
        the basis of its failure to meet such an additional requirement 
        before the first day of the first calendar quarter beginning 
        after the close of the first regular session of the State 
        legislature that begins after the date of the enactment of this 
        Act. For purposes of the previous sentence, in the case of a 
        State that has a 2-year legislative session, each year of the 
        session shall be considered to be a separate regular session of 
        the State legislature.

SEC. 3. MACPAC REPORT ON UTILIZATION OF MANAGEMENT CONTROLS ON THE 
              TREATMENT OF OPIOID USE DISORDER UNDER MEDICAID.

    Not later than 1 year after the date of enactment of this section, 
the Medicaid and CHIP Payment and Access Commission shall submit to 
Congress a report on issues related to utilization management controls 
for medication-assisted treatment of opioid use disorder under the 
Medicaid program. Such report shall include--
            (1) an analysis and description of the use of utilization 
        management controls for medication-assisted treatment furnished 
        through the Medicaid program across all States (as defined in 
        section 1101(a)(1) of the Social Security Act (42 U.S.C. 
        1301(a)(1)) for purposes of title XIX of such Act), including 
        dosing restrictions, age limits, counseling requirements, and 
        psychological screening requirements;
            (2) an assessment of the extent to which such utilization 
        management controls impose an administrative burden on 
        clinicians and other providers; and
            (3) an assessment of other Medicaid policies, at both the 
        Federal and State level, that impede patient access to 
        medication-assisted treatment and complicate clinician or 
        provider prescribing practices.
                                 <all>